Print this page
-
A Phase I Trial of Atezolizumab and Varlilumab in Combination with Radiation in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)
Protocol: 031912Principal Investigator:
- Jyoti Malhotra MD, MPH (Rutgers University)
Applicable Disease Sites: Lung -
A Phase 1 Study of Talimogene Laherparepvec and Panitumumab in Patients with Locally Advanced Squamous Cell Carcinoma of the Skin (SCCS)
Protocol: 091804Principal Investigator:
- Adam Berger (Rutgers University)
Applicable Disease Sites: Other Skin -
E4412: A Phase I Study with an Expansion Cohort of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma
Protocol: 011505Principal Investigator:
- Kevin David M.D (Rutgers University)
Applicable Disease Sites: Hodgkin's Lymphoma -
R3767-ONC-1613: A Phase 1, Open-Label, Dose-Escalation and Cohort Expansion First-in-Human Study of the Safety, Tolerability, Activity and Pharmacokinetics of REGN3767 (anti-LAG-3 mAb) Administered Alone or in Combination with REGN2810 (anti-PD-1 mAb) in Patients with Advanced Malignancies
Protocol: 051706Principal Investigator:
- Roman Groisberg M.D. (Rutgers University)
Applicable Disease Sites: Melanoma, Skin
Other Skin -
KEYNOYE-651: A Phase 1B Multi-Cohort Study of the Combination of Pembrolizumab (MK-3475) plus Binimetinib alone or the Combination of Pembrolizumab plus Chemotherapy with or without Binimetinib in Participants with Metastatic Colorectal Cancer (KEYNOTE-651)
Protocol: 051713Principal Investigator:
- Kristen Spencer DO, MPH (Rutgers University)
Applicable Disease Sites: Colon -
A Phase Ib Dose-Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab to Subjects with Locally Advanced or Metastatic Solid Tumors
Protocol: 051808Principal Investigator:
- Kristen Spencer DO, MPH (Rutgers University)
Applicable Disease Sites: Urinary Bladder
Prostate
Any Site
Lung
